Evidence map›Paper›PMID 32554749›Full record

ArticleCancer research2020

A Novel Locus Predicts Spermatogenic Recovery among Childhood Cancer Survivors Exposed to Alkylating Agents.

Yadav Sapkota, Carmen L Wilson, Asifa K Zaidi, Wonjong Moon, Klementina Fon Tacer, Lu Lu, Qi Liu, Jessica Baedke, Rikeenkumar Dhaduk, Zhaoming Wang and 8 more

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Yadav SapkotaDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. Yadav.Sapkota@stjude.org.ORCID 0000-0001-5943-9454
Carmen L WilsonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-7636-065X
Asifa K ZaidiSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-4515-1390
Wonjong MoonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-2544-1801
Klementina Fon TacerDepartment of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-1928-7745
Lu LuDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Qi LiuSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Jessica BaedkeDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-5085-4985
Rikeenkumar DhadukDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-1385-8044
Zhaoming WangDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Wassim ChemaitillyDivision of Endocrinology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Matthew J KrasinDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-5421-765X
Fred B BerryDepartment of Surgery, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-7307-8533
Jinghui ZhangDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-3350-9682
Melissa M HudsonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-6984-2407
Leslie L RobisonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Daniel M GreenDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-5156-5410
Yutaka YasuiDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
St. Jude Children's Research Hospital · USUniversity of Alberta · CA

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The St. Jude Lifetime CohortU01CA195547 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HUDSON, MELISSA M, NESS, KIRSTEN KIMBERLIE · 2015 to 2024
$14.9M
Late Effects Prediction using Clinical Phenotypes and Whole Genome SequencingR01CA216354 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI YASUI, YUTAKA, ZHANG, JINGHUI · 2017 to 2021
$3.4M
NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA216354NCI NIH HHS U01 CA195547
6 · The paper itself

Abstract

Exposure to high doses of alkylating agents is associated with increased risk of impaired spermatogenesis among nonirradiated male survivors of childhood cancer, but there is substantial variation in this risk. Here we conducted a genetic study for impaired spermatogenesis utilizing whole-genome sequencing data from 167 nonirradiated male childhood cancer survivors of European ancestry from the St. Jude Lifetime Cohort treated with cyclophosphamide equivalent dose (CED) ≥4,000 mg/m

Indexed as

Cancer SurvivorsAdultAntineoplastic Agents, AlkylatingChromosomes, Human, Pair 7CyclophosphamideGenetic MarkersHumansInfertility, MaleMaleMiddle AgedNeoplasmsPolymorphism, Single NucleotideSpermatogenesisYoung AdultAntineoplastic Agents, AlkylatingCyclophosphamideGenetic Markers

Identifiers

PMID32554749
PMCPMC7731186
OpenAlexW3036784533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.